Nuveen Fund Advisors
IDXX icon

Nuveen Fund Advisors’s Idexx Laboratories IDXX Stock Holding History

Nuveen Fund Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,670
Closed -$592K – 377
2017
Q2 		$592K Buy
3,670
+149
+4% +$24.2K 0.09% 241
2017
Q1 		$544K Sell
3,521
-334
-9% -$46K 0.07% 279
2016
Q4 		$452K Sell
3,855
-723
-16% -$82.5K 0.07% 294
2016
Q3 		$516K Sell
4,578
-501
-10% -$52.8K 0.07% 288
2016
Q2 		$472K Buy
+5,079
New +$436K 0.07% 280

Other funds holding IDXX

Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Nuveen Fund Advisors's IDXX Position: Q3 2017 in Review

Nuveen Fund Advisors sold out of Idexx Laboratories (IDXX) in Q3 2017, closing a stake of 3,670 shares — an estimated $592K sold.

Nuveen Fund Advisors first reported a position in IDXX in Q2 2016 and held it in 5 quarters. The position peaked at $592K in Q2 2017. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

  • Nuveen Fund Advisors reported no remaining Idexx Laboratories position as of Q3 2017 after selling out during the quarter.
  • Nuveen Fund Advisors sold 3,670 Idexx Laboratories shares in Q3 2017, an estimated $592K.
  • Nuveen Fund Advisors first reported a position in Idexx Laboratories in Q2 2016 and held it in 5 quarters.
  • Nuveen Fund Advisors's Idexx Laboratories position peaked at $592K in Q2 2017.
  • 573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on Nuveen Fund Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.